Promising Phase III Results for Alecensa in Early-Stage ALK-Positive Lung Cancer Pharma News & Analysis 1:50 1 year ago 254 Далее Скачать
Phase III Results for Alectinib Compared With Crizotinib in ALK+ Metastatic NSCLC Targeted Oncology 3:04 7 years ago 591 Далее Скачать
Alecensa: Targeted Therapy for ALK-Positive Lung Cancer Medical Centric 4:23 1 year ago 2 136 Далее Скачать
On the podcast: lung cancer in never smokers and the ALK positive mutation with Dr Fabio Gomes_Go 🫁 Faculty of Biology, Medicine and Health UoM 0:31 1 year ago 119 Далее Скачать
Updated Data from Phase 2 Study of Alectinib in ALK–Positive Non–Small–Cell Lung Cancer VJOncology 2:00 7 years ago 320 Далее Скачать
Phase 3 ALEX Study: Comparing Alecensa to Xalkori in ALK+ Lung Cancer Cancer Therapy Advisor 4:43 7 years ago 799 Далее Скачать
Dr. Gandhi Discusses the Role of Alectinib in ALK+ Lung Cancer OncLive 0:41 6 years ago 316 Далее Скачать
ALK Positive Lung Cancer in 2023 and Beyond: Thinking Outside the Box with Dr. Alice Shaw ALK Positive Inc. 42:31 1 year ago 4 630 Далее Скачать
ALINA: evaluating the safety of adjuvant alectinib for ALK+ NSCLC VJOncology 0:37 2 days ago 11 Далее Скачать
Clinical Trial Spotlight: ALCHEMIST for Early-Stage ALK+ and EGFR Lung Cancer Patients GRACE - Global Resource for Advancing Cancer Education 4:19 8 years ago 176 Далее Скачать
Dr. Solomon on the Results of the Phase 3 CROWN Study in ALK-Positive NSCLC OncLive 1:26 3 years ago 286 Далее Скачать
Dr. Shaw on Alectinib as First-Line Therapy in Lung Cancer OncLive 2:26 7 years ago 1 663 Далее Скачать
Targeting ALK rearrangements in non-small cell lung cancer VJOncology 1:01 1 year ago 324 Далее Скачать
A Practice Change for ALK+ Lung Cancer Patients, Alecensa for First Line Treatment GRACE - Global Resource for Advancing Cancer Education 6:33 7 years ago 1 609 Далее Скачать
Dr. Liu on Potentially Promising Combinations in ALK-Positive NSCLC OncLive 1:41 6 years ago 215 Далее Скачать
